Annotation Detail for ENOX1

Basic Information
Top
| Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
|---|
| D016604 |
Aflatoxin B1 |
Aflatoxin B1 affects the expression of ENOX1 protein | affects expression | 20106945
|
| D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of ENOX1 mRNA | decreases expression | 19150397
|
| C014347 |
decitabine |
decitabine results in decreased expression of ENOX1 mRNA | decreases expression | 19363521
|
| C014347 |
decitabine |
TP53 protein affects the reaction [decitabine results in decreased expression of ENOX1 mRNA] | affects reaction|decreases expression | 19363521
|
| Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
|---|
| MESH:D001943 |
Breast Neoplasms |
|
decitabine |
2.53 | 19208741 18320071 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
1.99 | 12619106 21507988 12907637 |
| MESH:D002294 |
Carcinoma, Squamous Cell |
|
decitabine |
2.69 | 19215824 |
| MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
3.01 | 20889678 |
| MESH:D003110 |
Colonic Neoplasms |
|
decitabine |
2.39 | 17616700 |
| MESH:D015179 |
Colorectal Neoplasms |
|
decitabine |
2.11 | 18981723 |
| MESH:D004701 |
Endocrine Gland Neoplasms |
|
decitabine |
5.98 | 19294695 |
| MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
2.15 | 20426865 |
| MESH:D006258 |
Head and Neck Neoplasms |
|
decitabine |
3.77 | 19215824 |
| MESH:D007248 |
Infertility, Male |
|
decitabine |
3.48 | 17581917 |
| MESH:D007938 |
Leukemia |
|
decitabine |
3.25 | 19235587 18980019 |
| MESH:D007951 |
Leukemia, Myeloid |
|
decitabine |
4.49 | 19117987 18454857 17236224 |
| MESH:D015470 |
Leukemia, Myeloid, Acute |
|
decitabine |
2.43 | 18460780 17679729 18704418 19010910 18206229 19387464 |
| MESH:D015477 |
Leukemia, Myelomonocytic, Chronic |
|
decitabine |
6.33 | 18055864 |
| MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
2.47 | 9163691 15890375 18177683 2125692 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
2.99 | 8603461 |
| MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
1.88 | 14755239 |
| MESH:D008223 |
Lymphoma |
|
decitabine |
3.73 | 19470736 |
| MESH:D008545 |
Melanoma |
|
decitabine |
2.29 | 16505122 17785578 |
| MESH:D009101 |
Multiple Myeloma |
|
decitabine |
3.65 | 18172295 |
| MESH:D009190 |
Myelodysplastic Syndromes |
|
decitabine |
3.60 | 16882708 18608210 19157545 19010910 |
| MESH:D009369 |
Neoplasms |
|
decitabine |
2.89 | 17925555 19116145 19470736 |
| MESH:D010051 |
Ovarian Neoplasms |
|
decitabine |
2.75 | 19259094 19331143 |
| MESH:D010190 |
Pancreatic Neoplasms |
|
decitabine |
2.89 | 19294695 |
| MESH:D055728 |
Primary Myelofibrosis |
|
decitabine |
5.38 | 17616702 |
| MESH:D012208 |
Rhabdomyosarcoma |
|
decitabine |
4.93 | 19155313 |
| MESH:D013274 |
Stomach Neoplasms |
|
decitabine |
2.10 | 19037991 |
| MESH:D013964 |
Thyroid Neoplasms |
|
decitabine |
3.67 | 17967635 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
decitabine |
2.85 | 19087683 17616700 |
| MESH:D014604 |
Uveal Neoplasms |
|
decitabine |
5.78 | 17785578 |